Establishing a Protocol for OPAT
Long-Acting Lipoglycopeptide Antibiotics for ABSSSI
Risk Stratification for ABSSSI
Cost Considerations for the Treatment of ABSSSI
Standard Protocol for the Treatment of ABSSSI
Lipoglycopeptide Antibiotics for ABSSSI: Education
OPAT Protocols: Navigating Challenges
Establishing Real-World Protocols for OPAT
Trends of ABSSSI Incidence in the Community
ABSSSI Case Scenarios for OPAT
Gram-Positive ABSSSI: Early Identification and Follow-Up
Lipoglycopeptide Therapies for Gram-Positive Infections
Determining the Severity of ABSSSI
ABSSSI: Outpatient Parenteral Antibiotic Therapy
Treatment of ABSSSI: Inpatient Versus Outpatient
Oral Antibiotic Compliance for ABSSSI
Cost Considerations of IV Antibiotics for ABSSSI
ABSSSI: Standard Protocol of Admission and Treatment
Understanding the Prevalence of ABSSSI in the Community
An Overview of ABSSSI
Positive Clinical Responses Reported for VIBATIV in Obese & Elderly Patients with cSSSIs
Researchers present positive new data from multiple studies of VIBATIV at the 2018 ECCMID conference in Madrid, Spain.
Treatment Options to Address the Threat of Carbapenem-Resistant Enterobacteriaceae
New agents are in development, but none represent a magic bullet for the problems that CRE infections present.
Long-Acting Anti-MRSA Agents: One Dose to Cure?
A review of the current literature and future directions.
What You Should Know About the Shingrix Vaccine for Shingles Prevention
This breakthrough vaccine is quickly becoming an integral part of the adult immunization arsenal.
Omadacycline Granted Priority Review by FDA
Paratek’s omadacycline moves another step toward approval.
HCT May Still Be Successful in Patients With Uncontrolled IFI Prior to Transplant
The results of a new study reveal that hematopoietic cell transplantation (HCT) may still be successful in cases with incomplete radiographic control of invasive fungal infection (IFI) prior to transplant.
Herpes Zoster Vaccine Subunit Prevents Herpes Zoster Episodes Following HSCT
The vaccine reduced the risk of herpes zoster by 68.2% in high-risk recipients of hematopoietic stem cell transplant.
Rezafungin Continues to Put Up Positive Results in Phase 1 & 2 Clinical Trials
Positive safety and efficacy results have been seen across 2 different dosing regimens as well as for any effects on QT prolongation.
Patient Registry Cuts Rates of Post-Splenectomy Complications
An Australian study found patients were better informed and more empowered when they signed up for a national registry of spleen disease patients.
Europe Responds to Recent Measles Outbreaks with Tougher Vaccination Laws
In the wake of Europe’s recent 4-fold increase in measles cases, countries such as Italy, Germany, and Romania are passing tougher laws requiring vaccinations for children being enrolled in school.
2 Clarke Drive Cranbury, NJ 08512